Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · IEX Real-Time Price · USD
31.47
+1.36 (4.52%)
At close: Jul 26, 2024, 4:00 PM
31.29
-0.18 (-0.57%)
After-hours: Jul 26, 2024, 4:48 PM EDT
Spyre Therapeutics Employees
Spyre Therapeutics had 30 employees as of December 31, 2023. The number of employees decreased by 39 or -56.52% compared to the previous year.
Employees
30
Change (1Y)
-39
Growth (1Y)
-56.52%
Revenue / Employee
$22,933
Profits / Employee
-$12,140,833
Market Cap
1.60B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
Teladoc Health | 5,600 |
Schrödinger | 867 |
Alphatec Holdings | 839 |
Supernus Pharmaceuticals | 652 |
BioCryst Pharmaceuticals | 536 |
MannKind | 414 |
Avadel Pharmaceuticals | 154 |
SYRE News
- 5 weeks ago - Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease - PRNewsWire
- 7 weeks ago - Spyre Therapeutics Announces Grants of Inducement Awards - PRNewsWire
- 2 months ago - Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference - PRNewsWire
- 2 months ago - Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors - PRNewsWire
- 2 months ago - Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Spyre Therapeutics Announces $180 Million Private Placement - PRNewsWire
- 5 months ago - Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - PRNewsWire
- 5 months ago - Spyre Therapeutics to Participate in the 44th Annual TD Cowen Health Care Conference - PRNewsWire